Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (181-190 of 975) with videos related to

Pageof 98
Sort By:
American Journal of Clinical Pathology|October 17, 2014
Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancerJohannes Giedl, Roland Schneckenpointner, Thomas Filbeck, et al.
Molecular Oncology|June 10, 2025
Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancerLaura Glossner, Markus Eckstein, Christoph Mark, et al.
European Urology|August 31, 2006
Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosisStefan Tritschler, Sonja Scharf, Alexander Karl, et al.
The American Journal of Surgical Pathology|January 2, 2007
Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutationsAbbas Agaimy, Peter H Wünsch, Ferdinand Hofstaedter, et al.
World Journal of Surgical Oncology|February 7, 2007
Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?Stefan Denzinger, Wolfgang Otto, Maximilian Burger, et al.
Frontiers in Immunology|February 21, 2022
The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological TumorsSimon Jasinski-Bergner, Markus Eckstein, Helge Taubert, et al.
European Urology|January 18, 2006
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutationsMaximilian Burger, Stefan Denzinger, Christine Hammerschmied, et al.
Virchows Archiv : an International Journal of Pathology|September 28, 2007
KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situAnja Dankof, Florian R Fritzsche, Edgar Dahl, et al.
The American Journal of Surgical Pathology|April 19, 2021
ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature ReviewAbbas Agaimy, Martina Baněčková, Stephan Ihrler, et al.
Clinical & Experimental Metastasis|August 8, 2025
Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinomaNadja Kührer, Irene Huebner-Resch, Roman Mayr, et al.
Pageof 98

Showing results (181-190 of 975) with videos related to

Sort By:
Pageof 98
American Journal of Clinical Pathology|October 17, 2014
Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancerJohannes Giedl, Roland Schneckenpointner, Thomas Filbeck, et al.
Molecular Oncology|June 10, 2025
Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancerLaura Glossner, Markus Eckstein, Christoph Mark, et al.
European Urology|August 31, 2006
Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosisStefan Tritschler, Sonja Scharf, Alexander Karl, et al.
The American Journal of Surgical Pathology|January 2, 2007
Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutationsAbbas Agaimy, Peter H Wünsch, Ferdinand Hofstaedter, et al.
World Journal of Surgical Oncology|February 7, 2007
Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?Stefan Denzinger, Wolfgang Otto, Maximilian Burger, et al.
Frontiers in Immunology|February 21, 2022
The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological TumorsSimon Jasinski-Bergner, Markus Eckstein, Helge Taubert, et al.
European Urology|January 18, 2006
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutationsMaximilian Burger, Stefan Denzinger, Christine Hammerschmied, et al.
Virchows Archiv : an International Journal of Pathology|September 28, 2007
KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situAnja Dankof, Florian R Fritzsche, Edgar Dahl, et al.
The American Journal of Surgical Pathology|April 19, 2021
ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature ReviewAbbas Agaimy, Martina Baněčková, Stephan Ihrler, et al.
Clinical & Experimental Metastasis|August 8, 2025
Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinomaNadja Kührer, Irene Huebner-Resch, Roman Mayr, et al.
Pageof 98